Drug Research
Eisai’s DAYVIGO gets approval in Japan to treat insomnia
Eisai Co., Ltd. announced that it has obtained the manufacturing and marketing approval in Japan for its in-house discovered orexin receptor antagonist DAYVIGO (2.5mg, 5mg,...
Drug Research
Eisai Commences Joint Research and Development of Cancer Gene...
Eisai Co., Ltd. announced that it has entered into a joint research and development agreement with Personal Genome Diagnostics Inc. for the cancer genetics panel...
Drug Research
Medigene, IRICoR and Universite de Montreal sign collaboration and...
Medigene AG , a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies, announces that it has entered into a research collaboration on...
Drug Research
Predictive Oncology Acquire Quantitative Medicine and an AI Engine...
Predictive Oncology Inc , a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery, announces it has signed a letter of...
Drug Research
FDF China to be held in June to boost...
FDF China, collocated with CPhI China, will be held from June 22-24, 2020 at Shanghai New International Expo Centre (SNIEC). More and more formulation enterprises...
Drug Research
Discover the Latest Information and Seize Market Opportunities in...
As the pharmaceutical market demands in China continue to grow, China’s pharmaceutical policies become gradually clear, which provides broad space for the development of pharmaceutical...
Drug Research
IONTAS and Adaptate Biotherapeutics collaborate to identify optimised antibodies...
IONTAS, a leader in the discovery and optimisation of fully human antibodies, announced it has entered into a collaboration agreement with Adaptate Biotherapeutics, developers of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.